| Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy A Moreau, JB Reisqs, H Delanoe‐Ayari, M Pierre, A Janin, A Deliniere, ... Clinical and translational medicine 11 (3), e319, 2021 | 21 | 2021 |
| The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy JB Reisqs, A Moreau, A Charrabi, Y Sleiman, AC Meli, G Millat, V Briand, ... Clinical and Translational Medicine 12 (3), 2022 | 15 | 2022 |
| Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells JB Reisqs, A Moreau, Y Sleiman, M Boutjdir, S Richard, P Chevalier Frontiers in Physiology 14, 1191965, 2023 | 7 | 2023 |
| Spironolactone as a potential new treatment to prevent arrhythmias in arrhythmogenic cardiomyopathy cell model JB Reisqs, A Moreau, Y Sleiman, A Charrabi, A Delinière, F Bessière, ... Journal of Personalized Medicine 13 (2), 335, 2023 | 6 | 2023 |
| Ion channel trafficking implications in heart failure JB Reisqs, YS Qu, M Boutjdir Frontiers in Cardiovascular Medicine 11, 1351496, 2024 | 2 | 2024 |
| Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model Y Sleiman, JB Reisqs, M Boutjdir International Journal of Molecular Sciences 25 (17), 9155, 2024 | 1 | 2024 |
| Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1 VKM Ginjupalli, M Cupelli, JB Reisqs, Y Sleiman, N El-Sherif, G Gourdon, ... Frontiers in Physiology 14, 1257682, 2023 | 1 | 2023 |
| Generation of an iPSC cell line (VANYHHi001-A) from a patient with cardiac arrythmias carrying CACNA1D, SCN5A, and DSP variants Y Sleiman, JB Reisqs, RB Tan, F Cecchin, M Chahine, M Boutjdir Stem Cell Research 81, 103608, 2024 | | 2024 |
| Calcium handling abnormalities increase arrhythmia susceptibility in DMSXL myotonic dystrophy type 1 mice M Cupelli, VKM Ginjupalli, JB Reisqs, Y Sleiman, N El-Sherif, G Gourdon, ... Biomedicine & Pharmacotherapy 180, 117562, 2024 | | 2024 |
| Development and characterization of a human cardiac cell model of arrhythmogenic cardiomyopathy JB Reisqs < bound method Organization. get_name_with_acronym of< Organization: TEL …, 2022 | | 2022 |
| Développement et caractérisation d’un modèle cellulaire cardiaque humain de cardiomyopathie arythmogène JB Reisqs Université de Lyon, 2022 | | 2022 |
Yvonne SleimanPostDoctoral Research AssociateAdresse e-mail validée de umontpellier.fr
